New mRNA vaccine shows promise against childhood cancer
New mRNA vaccine shows promise against childhood cancer
Updated at: June 19, 2026 at 08:00 AM
Medical researchers are making exciting strides in treating childhood cancer by adapting mRNA technology once used for COVID-19 vaccines.
While vaccines are usually for prevention, this new approach uses them as a therapeutic tool to fight existing tumors.
A recent breakthrough at the RCSI University of Medicine and Health Sciences focused on neuroblastoma, a particularly deadly childhood cancer.
By using peptide nanoparticles, scientists delivered mRNA instructions to train the immune system to hunt for a protein called GPC2 found on cancer cells.
Other initiatives are exploring personalized mRNA vaccines for childhood brain cancers.
By analyzing a child's specific tumor genetics, doctors can create custom treatments that re-educate the immune system to recognize and attack cancer cells it previously ignored.
While the field is still in early clinical stages, this innovative approach aims to prevent cancer relapse and significantly improve the quality of life for pediatric patients everywhere.
